Name,CAS,Conc,Effecti,AC10µM,pi,Endpoint(s)
Tetrabutylammonium bromide,1643-19-2,7.06213694234449e-07,1.20707281554155e-06,5.85063042710978,2.86566968653668e-06,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Domiphen bromide,538-71-6,0,0,4.66138461929374,0,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability
1-Hexyl-3-methylimidazolium bromide,85100-78-3,0,0,1.78268148034769,0,TOX21_AR_BLA_Antagonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Benzylquinolinium chloride,15619-48-4,1.44125243721316e-08,1.30334242170134e-07,1.10581257328507,5.84830548272791e-08,NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hM2|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT
"1,1-Dimethylpiperidinium chloride",24307-26-4,3.17075536186895e-07,2.19030758042518e-06,1.44763018226575,1.28662720620014e-06,NVS_LGIC_rNNR_BungSens
1-Benzyl-3-methylimidazolium chloride,36443-80-8,4.32375731163948e-08,4.7165182113306e-08,9.16726516872641,1.75449164481837e-07,TOX21_RT_HEK293_GLO_40hr_viability
Bethanechol chloride,590-63-6,1.29712719349185e-07,6.58598586967583e-07,1.96952623215344,5.26347493445512e-07,TOX21_RT_HEPG2_FLO_08hr_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
Dodecyltrimethylammonium chloride,112-00-5,0,0,1.03343371913131,0,NVS_ENZ_rMAOBC|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hDRD1|NVS_GPCR_hDRD2s|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_IC_hKhERGCh|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_hNET|NVS_TR_rSERT
Benzyldimethyldodecylammonium chloride,139-07-1,0,0,3.9465227750746,0,ATG_XTT_Cytotoxicity_up|TOX21_ARE_BLA_agonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_ESRE_BLA_viability|TOX21_HSE_BLA_agonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_VDR_BLA_antagonist_viability
Methylene blue,61-73-4,2.88250487442632e-08,9.10369672453329e-07,0.316630151645797,1.16966109654558e-07,TOX21_MMP_rhodamine
Colchicine,64-86-8,5.40469663954935e-06,0.016214089908182,0.00333333333548497,2.19311455602297e-05,CCTE_Mundy_HCI_Cortical_NOG_BPCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_hN2_NOG_NeuronCount_loss|CCTE_Mundy_HCI_hNP1_Casp3_7_gain|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|CNS neurite outgrowth|SH-S5Y5 neurite outgrowth
Betamethasone,378-44-9,7.20626218606581e-08,2.92490845504331e-05,0.0246375648907587,2.92415274136395e-07,TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Estrone,53-16-7,8.35926413583634e-07,5.76834924561784e-06,1.44916054487977,3.39201717998219e-06,BSK_hDFCGF_Proliferation_down|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Heptachlor epoxide B,1024-57-3,1.77274049777219e-06,3.12224353911911e-05,0.56777777760166,7.19341574375533e-06,BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
Stilonium iodide,77257-42-2,8.64751462327897e-08,2.53303012276159e-07,3.41390121877081,3.50898328963674e-07,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability
"1-Butyl-2,3-dimethylimidazolium iodide",108203-70-9,4.52553265284933e-06,1.30742630398874e-05,3.46140554082681,1.83636792157656e-05,TOX21_RT_HEPG2_GLO_40hr_viability
Maneb,12427-38-2,4.32375731163948e-08,0.000129712719265456,0.00333333333548497,1.75449164481837e-07,NS-ISI
Imidacloprid,138261-41-3,1.44125243721316e-08,2.99132175450293e-07,0.48181123780603,5.84830548272791e-08,NVS_LGIC_hNNR_NBungSens|#SiNS|SH-S5Y5 neurite outgrowth
"1,3-Dinitrobenzene",99-65-0,1.72950292465579e-06,8.09963181087626e-05,0.213528585624522,7.01796657927349e-06,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_ENZ_rMAOBP
4-Nitropyridine-1-oxide,1124-33-0,3.38694322745093e-06,3.44132159556566e-06,9.84198405582089,1.37435178844106e-05,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability
"1,4-Dinitrobenzene",100-25-4,2.46165916276008e-05,2.76754011977415e-05,8.89475511184627,9.98890576449927e-05,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability
"1-Fluoro-2,4-dinitrobenzene",70-34-8,3.24281798372961e-06,9.38128342621497e-05,0.345668906523804,1.31586873361378e-05,TOX21_MMP_ratio_down
"1,8-Dinitronaphthalene",602-38-0,3.6031310930329e-06,1.73956916279234e-05,2.07127786011634,1.46207637068198e-05,TOX21_MMP_rhodamine
1-Methyl-3-hexylimidazolium trifluoromethylsulfonate,460345-16-8,0,0,3.95579295369595,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Brolamfetamine hydrobromide,53581-53-6,1.44125243721316e-08,3.1461287159405e-08,4.58103455815639,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Pentabromoethane,75-95-6,5.76500974885265e-07,3.8556931978222e-07,14.9519410727723,2.33932219309116e-06,TOX21_HRE_BLA_Agonist_viability
"2,2',4,4',5-Pentabromodiphenyl ether",60348-60-9,5.26345390070247e-05,0.00099279407541031,0.530165724299588,0.000213580116229223,TOX21_MMP_fitc
"4,4'-Dibromodiphenyl ether",2050-47-7,4.4678825553608e-06,1.60170425690074e-05,2.78945537923839,1.81297469964565e-05,TOX21_MMP_fitc
"1,2,5,6,9,10-Hexabromocyclododecane",3194-55-6,0.000281188350500288,0.000487966574716439,5.76245105853179,0.00114100439968021,TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability
"1,2-Dibromo-2,4-dicyanobutane",35691-65-7,2.73837963070501e-07,1.29396368688719e-06,2.11627239501021,1.1111780417183e-06,NVS_GPCR_hDRD1|NVS_GPCR_hORL1|NVS_TR_gDAT
"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",3322-93-8,2.66631700884435e-06,3.52180628652876e-06,7.57087923615579,1.08193651430466e-05,TOX21_MMP_ratio_down
"1,4-Butanediol diglycidyl ether",2425-79-8,0,0,0.645110143412394,0,TOX21_RT_HEK293_GLO_40hr_viability
N-Benzyladenine,1214-39-7,3.15634283749682e-05,2.2849025576012e-05,13.8139056608633,0.000128077890071741,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
4-(Diglycidylamino)phenyl glycidyl ether,5026-74-4,0,0,7.62065053061028,0,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability
Rutin,153-18-4,3.14193031312469e-06,3.47376306759366e-06,9.04474557414524,1.27493059523468e-05,TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Cantharidin,56-25-7,1.44125243721316e-08,4.38780122332672e-06,0.0328468033043767,5.84830548272791e-08,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
alpha-Tomatine,17406-45-0,3.90579410484767e-06,4.46796967848207e-05,0.874176502060463,1.58489078581926e-05,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Paraquat,4685-14-7,3.80490643424275e-06,0.005227193567368,0.00727906167086634,1.54395264744017e-05,SH-S5Y5 viability
"2E,4E-Hexadienoic acid",110-44-1,2.6057844064814e-05,3.34672319901167e-05,7.7860768624394,0.000105737363127721,APR_HepG2_MitoMass_72h_up
"(2,4,6-Trioxo-1,3,5-triazinane-1,3,5-triyl)triethane-2,1-diyl trisprop-2-enoate",40220-08-4,0,0,5.55548761892791,0,ATG_XTT_Cytotoxicity_up|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
Diethylene glycol diacrylate,4074-88-8,0,0,20.318483085749,0,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
Diallyl phthalate,131-17-9,1.2048870375102e-05,4.14205619451062e-05,2.90891040808914,4.88918338356053e-05,NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|SYNCHRONY_INDEX
Diquat,2764-72-9,2.92718369997993e-05,7.33724571387444,3.98948572002263e-05,0.000118779084354204,SH-S5Y5 neurite outgrowth
"5,6,7,8-Tetrahydroquinoxaline",34413-35-9,4.29493226289522e-06,1.08520072433632e-05,3.9577307373453,1.74279503385292e-05,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability
Piperazine,110-85-0,2.03216593647056e-06,8.10967167576115e-05,0.25058547592555,8.24611073064635e-06,NVS_LGIC_rGABAR_NonSelective
Mepanipyrim,110235-47-7,2.30600389954106e-07,3.29412133472438e-06,0.700036114405603,9.35728877236465e-07,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
3-Methylbut-3-en-1-ol,763-32-6,4.5010313614167e-05,1.4414613722805e-05,31.2254733145969,0.000182642580225593,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Methyl trans-styryl ketone,1896-62-4,0,0,11.4035274127695,0,BSK_3C_Proliferation_down|BSK_SAg_Proliferation_down
Diacetone alcohol,123-42-2,8.42700300038536e-05,0.00143131242860908,0.588760555134321,0.000341950421575101,APR_HepG2_MitoMass_24h_dn
Acenocoumarol,152-72-7,2.83926730130993e-06,1.67808132452442e-05,1.69197240909322,1.1521161800974e-05,TOX21_MMP_rhodamine
Warfarin,81-81-2,1.29712719349185e-06,3.10250505467587e-06,4.18090275642552,5.26347493445512e-06,TOX21_MMP_ratio_down
N-Acetyl-m-toluidine,537-92-8,2.88250487442632e-08,2.60670303756008e-08,11.0580485498049,1.16966109654558e-07,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Acetyl-2-phenylhydrazine,114-83-0,2.88250487442632e-08,1.06269653158307e-07,2.71244404094584,1.16966109654558e-07,TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
5-Nitro-2-furanmethanediol diacetate,92-55-7,4.00668177545259e-06,3.19661364306805e-06,12.5341446381585,1.62582892419836e-05,TOX21_Aromatase_Inhibition_viability
Adefovir dipivoxil,142340-99-6,0,0,0.414304278567089,0,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability
Triadimenol,55219-65-3,2.45012914326237e-07,0.00018187384777252,0.0134715857902061,9.94211932063744e-07,NVS_TR_gDAT|NVS_TR_hDAT
"2,6-Di-tert-butylphenol",128-39-2,3.44459332493946e-06,1.14012731844315e-06,30.2123567185731,1.39774501037197e-05,APR_HepG2_CellLoss_24h_dn|NCCT_HEK293T_CellTiterGLO
Clofoctol,37693-01-9,5.3874016103028e-05,0.000771991668266123,0.69785748107914,0.000218609658944369,TOX21_MMP_rhodamine
"4,4'-(Isopropylidenebis(4,1-phenyleneoxy))dianiline",13080-86-9,2.16187865581974e-06,3.14888699644405e-06,6.86553267316702,8.77245822409186e-06,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Chloro-2-nitropropane,594-71-8,6.34151072373791e-07,2.34842779034047e-05,0.27003217854182,2.57325441240028e-06,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
2-Acrylamido-2-methyl-1-propanesulfonic acid,15214-89-8,2.73837963070501e-06,4.76811855895344e-06,5.74310306433752,1.1111780417183e-05,TOX21_RT_HEPG2_FLO_00hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
Hydroxyflutamide,52806-53-8,3.38694322745093e-06,0.00024472186516342,0.138399698171195,1.37435178844106e-05,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_72h_dn|TOX21_MMP_ratio_down
Esfenvalerate,66230-04-4,2.93294870972878e-05,0.00353971195155784,0.0828584006231915,0.000119013016573513,NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Isopropamide,7492-32-2,1.00887670604921e-07,2.79557968205158e-07,3.608828296065,4.09381383790954e-07,TOX21_RT_HEPG2_GLO_40hr_viability
Allethrin,584-79-2,2.45012914326237e-07,2.83840691720439e-06,0.863205739956257,9.94211932063744e-07,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
Riboprine,7724-76-7,8.64751462327897e-08,5.8306642057148e-07,1.48310969697128,3.50898328963674e-07,TOX21_ARE_BLA_agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability
"2,2,4-Trimethyl-1,3-pentanediol",144-19-4,3.31488060559027e-07,8.32386881782931e-06,0.398237968201753,1.34511026102742e-06,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Imazapyr,81334-34-1,1.70067787591153e-06,0.00578664223445161,0.00293897187178136,6.90100046961893e-06,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|INTER_BURST_INTERVAL_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
Deethylatrazine,6190-65-4,1.9168657414935e-06,0.0042960511918135,0.00446192481399258,7.77824629202812e-06,SH-S5Y5 neurite outgrowth
Oxadiazon,19666-30-9,1.31153971786398e-06,0.000907600284758766,0.0144506314055705,5.3219579892824e-06,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE
"4,4-Bis(4-hydroxyphenyl)valeric acid",126-00-1,4.17963206791817e-06,5.20050753155068e-05,0.803696955068516,1.69600858999109e-05,ACEA_AR_antagonist_AUC_viability
Bicalutamide,90357-06-5,2.98339254503124e-06,0.0179286593376664,0.00166403549135624,1.21059923492468e-05,SH-S5Y5 viability
"2-Methyl-2,4-pentanediol",107-41-5,0.000102761298773298,7.11257841728752e-05,14.447826476476,0.0004169841809185,APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down
meso-Hexestrol,84-16-2,4.06433187294112e-06,2.61060176316649e-05,1.55685632725971,1.64922214612927e-05,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_D1|NVS_GPCR_rOpiate_NonSelective|NVS_TR_gDAT
Azithromycin,83905-01-5,8.64751462327897e-08,1.06506173769024e-06,0.81192613697986,3.50898328963674e-07,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability
Tamoxifen,10540-29-1,1.16741447414266e-06,1.18183833650852e-05,0.987795401519573,4.73712744100961e-06,NVS_GPCR_hDRD1|NVS_IC_rCaBTZCHL|NVS_TR_hDAT|NUMBER_OF_SPIKES|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
trans-Hex-3-en-1-ol,928-97-2,7.20626218606581e-08,1.28621694997515e-07,5.60268015921032,2.92415274136395e-07,TOX21_PR_BLA_Agonist_viability
Clomazone,81777-89-1,0,0,0.0488789124037467,0,NVS_TR_hDAT|SH-S5Y5 neurite outgrowth
"5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin",63612-50-0,2.96898002065911e-06,7.43996726604196e-06,3.99058210136266,1.20475092944195e-05,NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective
"2,3-Dimethylphenol",526-75-0,0,0,0.149726139097127,0,ACEA_AR_antagonist_AUC_viability|TOX21_RT_HEK293_FLO_08hr_viability
Terbacil,5902-51-2,0,0,0.887543958494256,0,BSK_SAg_PBMCCytotoxicity_up
4-Chloro-3-methylphenol,59-50-7,2.45012914326237e-07,0.000410631753083169,0.00596673083575719,9.94211932063744e-07,SH-S5Y5 viability
Rimonabant,168273-06-1,3.04104264251977e-06,0.000102950997899267,0.295387388619128,1.23399245685559e-05,TOX21_RT_HEK293_GLO_40hr_viability
2-Amino-m-cresol,2835-97-4,4.32375731163948e-08,2.20515541674583e-09,196.074946863387,1.75449164481837e-07,TOX21_RT_HEK293_GLO_40hr_viability
"4,4'-Diamino-3,3'-dimethyldiphenylmethane",838-88-0,5.76500974885265e-08,1.70322277402187e-07,3.38476553788649,2.33932219309116e-07,APR_HepG2_MitoMass_72h_up|NCCT_MITO_basal_resp_rate_OCR_dn|NVS_TR_hDAT|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
4-Chloro-2-methylaniline,95-69-2,4.32375731163948e-08,1.17721054384792e-06,0.367288360967827,1.75449164481837e-07,ACEA_ER_AUC_viability|BSK_3C_Proliferation_down
"2-Methyl-4,6-dinitrophenol",534-52-1,1.47007748595742e-06,1.68631845049303e-06,8.7176742063613,5.96527159238247e-06,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_72h_up|BSK_SAg_PBMCCytotoxicity_up|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_AhR_LUC_Agonist_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_MMP_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
Methylhydroquinone,95-71-6,1.44125243721316e-08,9.2201816926336e-09,15.6314971359473,5.84830548272791e-08,TOX21_RXR_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"2-Methyl-1,3-benzenediol",608-25-3,2.88250487442632e-08,7.39300296903622e-07,0.389896350170423,1.16966109654558e-07,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down
MCPA,94-74-6,3.41576827619519e-05,0.000226067332117562,1.51095173468888,0.000138604839940651,ACEA_AR_antagonist_AUC_viability
Tiliquinol,5541-67-3,0,0,2.13586263652171,0,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
"4-Methyl-2,6-dinitrophenol",609-93-8,3.55989351991651e-06,6.03943616415757e-06,5.89441368888625,1.44453145423379e-05,TOX21_MMP_rhodamine
2-Methyl-4-nitroaniline,99-52-5,0,0,16.1935867262736,0,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"3,3'-Dimethylbenzidine",119-93-7,4.02830056201079e-05,0.000279514104537453,1.44117971029652,0.000163460138242245,ACEA_AR_antagonist_AUC_viability|BSK_SAg_Proliferation_down
Isophorone,78-59-1,3.17075536186895e-07,0.0012116050621392,0.00261698754895485,1.28662720620014e-06,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
"3,5-Dimethylpyridine",591-22-0,5.43352168829362e-06,6.01341258943517e-05,0.903567085657759,2.20481116698842e-05,ACEA_ER_AUC_viability
"4,4'-Thiobis(6-tert-butyl-m-cresol)",96-69-5,0.000521733382271164,0.000564916857076377,9.23557822245381,0.0021170865847475,TOX21_AP1_BLA_Agonist_viability|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_HSE_BLA_agonist_viability|TOX21_NFkB_BLA_agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability|TOX21_p53_BLA_p5_viability
4-Methylcatechol,452-86-8,1.44125243721316e-08,7.26662688567217e-09,19.8338577153992,5.84830548272791e-08,TOX21_SSH_3T3_GLI3_Agonist_viability
"3,4-Dinitrotoluene",610-39-9,3.45900584931159e-06,2.65355207309816e-05,1.30353795743417,1.4035933158547e-05,NVS_ENZ_rMAOAC
Clofilium tosylate,92953-10-1,1.44125243721316e-08,1.19569374426396e-07,1.20536922111302,5.84830548272791e-08,TOX21_TR_RXR_BLA_Antagonist_Followup_viability
2-Dodecylisoquinolinium tosylate,5412-37-3,1.44125243721316e-08,5.12741197503697e-08,2.8108769964847,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Diiodomethyl 4-methylphenyl sulfone,20018-09-1,1.06652680353774e-06,2.4271294140687e-05,0.439419009697498,4.32774605721865e-06,NVS_GPCR_hDRD1|NVS_TR_rVMAT2
"3,4-Diaminotoluene",496-72-0,1.87362816837711e-07,1.7845905234371e-06,1.04989247884637,7.60279712754628e-07,INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
C.I. Solvent Orange 7,3118-97-6,2.49336671637877e-06,1.51217006658671e-05,1.64886660004244,1.01175684851193e-05,BSK_SAg_Proliferation_down|TOX21_CASP3_CHO_viability|TOX21_PXR_viability
1-Phenyl-3-methyl-5-pyrazolone,89-25-8,8.64751462327897e-08,1.26981473174662e-07,6.8100600875723,3.50898328963674e-07,TOX21_MMP_rhodamine
"2,2-Dichloro-1-(3-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl)ethanone",98730-04-2,0,0,3.14127675233068,0,ACEA_AR_agonist_AUC_viability|ACEA_ER_AUC_viability|BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_CASM3C_SRB_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Flopropione,2295-58-1,0,0,2.01549724460801,0,TOX21_MMP_ratio_down
Iopanoic acid,96-83-3,2.88250487442632e-06,9.20417840923159e-05,0.313173511666748,1.16966109654558e-05,ACEA_AR_agonist_AUC_viability
2-Ethylphenol,90-00-6,0,0,2.90693303691364,0,TOX21_RT_HEK293_FLO_40hr_viability
"2,2'-Methylenebis(ethyl-6-tert-butylphenol)",88-24-4,0.000736047619684761,0.0188816196553714,0.389822289146351,0.00298672961002914,TOX21_MMP_rhodamine
Enefexine,67765-04-2,8.64751462327897e-08,2.83230081392225e-07,3.05317661908364,3.50898328963674e-07,TOX21_PR_BLA_Agonist_viability
Metolachlor ESA,171118-09-5,1.9168657414935e-06,9.58667815133377e-07,19.9950985235362,7.77824629202812e-06,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Imazethapyr,81335-77-5,2.88250487442632e-08,2.32917000595504e-05,0.0123756740257541,1.16966109654558e-07,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
Pyrimethamine,58-14-0,0,0,0.404722447982603,0,NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C
Valproic acid,99-66-1,2.88250487442632e-08,3.7466485439487e-09,76.935555620287,1.16966109654558e-07,%SiNS|NSDsd|#SiNS
6-Propyl-2-thiouracil,51-52-5,2.45012914326237e-07,0.000244244224794925,0.0100314721681529,9.94211932063744e-07,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION
MEHP,4376-20-9,2.53660428949516e-06,4.06649228602604e-05,0.623781901225256,1.02930176496011e-05,NCCT_MITO_basal_resp_rate_OCR_dn
gamma-Decanolactone,706-14-9,2.88250487442632e-08,2.86092310594205e-07,1.00754363807942,1.16966109654558e-07,ACEA_AR_antagonist_AUC_viability
5-Heptyldihydro-2(3H)-furanone,104-67-6,7.20626218606581e-08,3.14954607805282e-07,2.28803199174689,2.92415274136395e-07,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
"N,N-Dimethyldecylamine oxide",2605-79-0,0,0,4.95638712464101,0,TOX21_MMP_ratio_up
Lauryl gallate,1166-52-5,4.7417205184313e-06,2.37665207313718e-05,1.9951260733643,1.92409250381748e-05,TOX21_MMP_ratio_down
Decyl beta-D-glucopyranoside,58846-77-8,0,0,1.03480496138248,0,TOX21_RT_HEK293_GLO_32hr_viability
Di-n-octyl phthalate,117-84-0,0.233338769584811,1.2925725184925,1.80522768546053,0.946840657653648,BSK_SAg_PBMCCytotoxicity_up
Carmofur,61422-45-5,1.44125243721316e-08,5.93981983590682e-08,2.42642449944465,5.84830548272791e-08,TOX21_ERb_BLA_Agonist_viability
N-Butylbenzenesulfonamide,3622-84-2,0.000957279868796982,0.00967363446030647,0.989576226727358,0.00388444450162788,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Butoxyethanol,111-76-2,0.000144989995183644,0.0168418914747901,0.0860889024256411,0.000588339531562428,SH-S5Y5 neurite outgrowth
"3,6,9,12-Tetraoxahexadecan-1-ol",1559-34-8,1.44125243721316e-07,2.94470208898585e-07,4.89439132944523,5.84830548272791e-07,TOX21_PR_BLA_Antagonist_viability
Dibutyl butylphosphonate,78-46-6,6.65137999773874e-05,4.70866884651795e-05,14.1258181761018,0.000269899298027893,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability
Tributyl phosphate,126-73-8,0.00081142512215101,0.00388989600707637,2.08598152926169,0.00329259598677581,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
Propylparaben,94-13-3,0,0,0.713099042501998,0,NVS_GPCR_hAdoRA1|NVS_TR_hDAT
Oxibendazole,20559-55-1,0,0,0.0878313412227301,0,TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Albendazole oxide,54029-12-8,1.44125243721316e-08,6.36022641492738e-08,2.26603951367291,5.84830548272791e-08,TOX21_RT_HEK293_GLO_40hr_viability
4-(Diethylamino)salicylaldehyde,17754-90-4,0,0,5.33250859943809,0,TOX21_RXR_BLA_Agonist_viability
4-(Diethylamino)benzaldehyde,120-21-8,0,0,1.88355662383692,0,NVS_TR_rSERT
"N,N-Diethyl-p-phenylenediamine",93-05-0,1.44125243721316e-08,3.94250379561243e-08,3.65567799533159,5.84830548272791e-08,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_MMP_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_VDR_BLA_Agonist_viability
"N-Ethyl-N-(3-methylphenyl)ethane-1,2-diamine",19248-13-6,4.4678825553608e-07,2.03635487844474e-07,21.9405890527939,1.81297469964565e-06,TOX21_RT_HEPG2_FLO_24hr_viability
Cyanazine,21725-46-2,3.02663011814764e-07,1.85249793538392e-06,1.63381025173471,1.22814415137286e-06,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1
Atrazine,1912-24-9,1.31153971786398e-06,7.04772501348933e-06,1.8609405380512,5.3219579892824e-06,NVS_GPCR_bAdoR_NonSelective|NUMBER_OF_BURSTS|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX|SH-S5Y5 neurite outgrowth
N-Ethylperfluorooctanesulfonamide,4151-50-2,1.90245321712137e-06,1.5232405006286e-06,12.4895130896026,7.71976323720084e-06,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_MicrotubuleCSK_72h_up|TOX21_ARE_BLA_agonist_viability
Ethyl 4-oxo-1-piperidinecarboxylate,29976-53-2,1.0290542401702e-05,0.000527628736677886,0.195033774439474,4.17569011466773e-05,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
"Ethyl 4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-2-yl)piperidine-1-carboxylate",53786-46-2,0,0,0.50224826054555,0,TOX21_CAR_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability
Thiophanate,23564-06-9,0,0,21.5860580979083,0,TOX21_RT_HEK293_GLO_16hr_viability
2-Ethoxyaniline,94-70-2,1.44125243721316e-08,1.3498075446216e-07,1.06774661540153,5.84830548272791e-08,TOX21_RT_HEK293_GLO_40hr_viability
2-Ethoxy-5-(1-propenyl)phenol,94-86-0,0,0,0.728521911778959,0,NVS_TR_hNET
Oxyfluorfen,42874-03-3,1.39801486409677e-06,6.83295219697237e-06,2.04598952809331,5.67285631824607e-06,TOX21_MMP_rhodamine
4-Ethoxyphenol,622-62-8,0,0,8.58972442780259,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
Tralkoxydim,87820-88-0,2.73837963070501e-07,6.28293241714755e-06,0.435844196450585,1.1111780417183e-06,NVS_GPCR_hAdra2A|NVS_GPCR_rmAdra2B
Ethyl 4-nitrophenyl ethylphosphonate,546-71-4,0,0,6.61952013790233,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability
Paraoxon,311-45-5,2.04657846084269e-06,0.0111392777318424,0.00183726316024279,8.30459378547363e-06,SH-S5Y5 neurite outgrowth
Diazoxon,962-58-3,0,0,0.00467189774716212,0,SH-S5Y5 neurite outgrowth
Ethyl dichlorophosphate,1498-51-7,4.02109429982472e-06,7.39214175330616e-05,0.543968775764652,1.63167722968109e-05,TOX21_RT_HEK293_GLO_32hr_viability
Molinate,2212-67-1,1.38360233972463e-06,2.29363854169261e-05,0.603234692203765,5.61437326341879e-06,NVS_GPCR_hM2
Mabuterol hydrochloride,54240-36-7,2.88250487442632e-08,1.26847480875728e-07,2.27241791049071,1.16966109654558e-07,TOX21_AhR_LUC_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Proguanil hydrochloride,637-32-1,1.44125243721316e-08,1.06955187598327e-07,1.34752924993767,5.84830548272791e-08,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
Isoproterenol hydrochloride,51-30-9,4.2372821654067e-06,2.99955583550932e-05,1.41263653613143,1.71940181192201e-05,NVS_GPCR_rAdrb_NonSelective|NVS_TR_hDAT|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE
2-Chloropropyldimethylamine hydrochloride,4584-49-0,1.26830214474758e-06,7.972838259279e-07,15.9077872082943,5.14650882480056e-06,BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down
Cycloguanil hydrochloride,152-53-4,4.28051973852309e-06,2.58771169231347e-05,1.65417181181271,1.73694672837019e-05,TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability
"(-)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",42011-76-7,2.88250487442632e-08,3.32297692471329e-08,8.67446551611258,1.16966109654558e-07,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability
"(+)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",50505-91-4,1.44125243721316e-08,2.84304819373668e-08,5.06939150869227,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Irinotecan hydrochloride,100286-90-6,0,0,1.40323754720254,0,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Benzidine dihydrochloride,531-85-1,0,0,4.13775695063119,0,TOX21_ERb_BLA_Agonist_viability
N-(1-Naphthyl)ethylenediamine dihydrochloride,1465-25-4,4.32375731163948e-08,5.35779781370362e-08,8.07002701852732,1.75449164481837e-07,TOX21_ERb_BLA_Antagonist_viability|TOX21_RT_HEK293_GLO_00hr_viability
Clonidine hydrochloride,4205-91-8,1.44125243721316e-08,5.91522220844614e-09,24.3651444768253,5.84830548272791e-08,TOX21_PR_BLA_Antagonist_viability
"1,3-Dichloro-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline hydrochloride (1:1)",149062-75-9,1.44125243721316e-08,6.00483275937827e-07,0.240015416742828,5.84830548272791e-08,NVS_ENZ_hAChE|NVS_ENZ_rAChE|NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_hAdra2A|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|NVS_TR_hNET
Dexchlorpheniramine hydrochloride,5502-69-2,3.6031310930329e-07,7.27927260383857e-07,4.94985047150572,1.46207637068198e-06,TOX21_PXR_viability
Clomipramine hydrochloride,17321-77-6,8.35926413583633e-06,1.08397905983993e-05,7.71164724996693,3.39201717998219e-05,ATG_XTT_Cytotoxicity_up|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability
Diphenhydramine hydrochloride,147-24-0,4.92187707308294e-05,0.000812857070527861,0.605503384486368,0.000199719632235158,NVS_ENZ_hES|NVS_GPCR_gMPeripheral_NonSelective|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hDRD1|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hM5|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rOpiate_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rCaBTZCHL|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_h5HT2A|NVS_GPCR_h5HT7|NVS_GPCR_p5HT2C|NVS_GPCR_r5HT_NonSelective|NVS_TR_rSERT|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Naftifine hydrochloride,65473-14-5,2.69514205758861e-06,1.57248729697221e-05,1.71393566280506,1.09363312527012e-05,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RXR_BLA_Agonist_viability
-Methyl-2H-isothiazol-3-one hydrochloride,26172-54-3,4.32375731163948e-08,4.19018787406231e-08,10.3187671808321,1.75449164481837e-07,TOX21_CASP3_CHO_viability
"L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride",1421-65-4,1.00887670604921e-07,2.06129957279946e-07,4.89437207168801,4.09381383790954e-07,TOX21_Aromatase_Inhibition_viability
"R-(-)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-92-5,1.44125243721316e-08,3.07967669634066e-08,4.67988227116726,5.84830548272791e-08,TOX21_ERb_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
"S-(+)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",50505-93-6,1.44125243721316e-08,4.30355905628639e-08,3.34897794677143,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability
"4-Bromo-2,5-dimethoxyamphetamine hydrochloride",29705-96-2,1.44125243721316e-08,2.70199685035728e-08,5.33402708083315,5.84830548272791e-08,TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability
p-Anisidinium chloride,20265-97-8,2.88250487442632e-08,4.14434132035637e-07,0.695527865976651,1.16966109654558e-07,ACEA_ER_AUC_viability|NCCT_HEK293T_CellTiterGLO
1-Phenylcyclohexylamine hydrochloride,1934-71-0,0,0,8.01988935521013,0,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
C.I. Basic Red 9 monohydrochloride,569-61-9,0,0,1.80200440245791,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_ELG1_LUC_Agonist_viability|TOX21_ERR_viability|TOX21_ERa_BLA_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_MMP_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_PXR_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RAR_LUC_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
4-Chloroaniline hydrochloride,20265-96-7,3.25723050810175e-06,2.58848769286621e-05,1.25835271192464,1.32171703909651e-05,ACEA_ER_AUC_viability
C.I. Basic Orange 2,532-82-1,0,0,0.864668741834001,0,TOX21_MMP_ratio_down
"2'-Deoxy-2',2'-difluorocytidine monohydrochloride",122111-03-9,7.20626218606581e-08,1.66368516938806e-06,0.433150593553493,2.92415274136395e-07,TOX21_RT_HEK293_GLO_40hr_viability
Lindane,58-89-9,1.98748711091695e-05,0.000117371286078741,1.69333333331937,8.06481326068179e-05,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION|MFR|BR|BD|IBI|#NS|NSDsd|#SiNS|LD movement pattern (pearson) 5dpf|b D1 distmoved 5dpf|percent scrunching Tail 12d|mean firing rate|number network spikes|percent affected 4dpf|a L1 distmoved 5dpf|LD movement pattern (spearman) 1dpf|LD movement pattern (spearman) 5dpf|e L3 distmoved 5dpf
Captan,133-06-2,1.38360233972463e-06,4.35408640320178e-06,3.17770988354113,5.61437326341879e-06,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_FXR_BLA_agonist_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"o,p'-DDE",3424-82-6,1.75832797340006e-06,2.4921158720776e-06,7.05556267708449,7.13493268892805e-06,BSK_3C_Proliferation_down|BSK_3C_Vis_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
MON-4660,71526-07-3,0,0,1.89360426471797,0,ACEA_ER_AUC_viability
"1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane",53-19-0,1.48449001032956e-06,0.00349636271411341,0.00424581238192842,6.02375464720975e-06,TOX21_RT_HEK293_FLO_24hr_viability
"p,p'-DDD",72-54-8,1.67185282716727e-06,1.53813979831572e-05,1.08693164886441,6.78403435996437e-06,APR_HepG2_MitoMembPot_24h_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
"2,2'-Dichlorobiphenyl",13029-08-8,3.11310526438043e-06,7.0431098416263e-06,4.42007200566617,1.26323398426923e-05,TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
Dieldrin,60-57-1,1.49890253470169e-06,0.0207415531691662,0.000722656843716947,6.08223770203702e-06,SH-S5Y5 viability
Aldrin,309-00-2,1.42683991284103e-06,1.74640762383245e-06,8.1701424877536,5.78982242790063e-06,APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|BSK_3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_PPARd_BLA_Agonist_viability
Isodrin,465-73-6,1.70067787591153e-06,3.88242572409402e-06,4.38045180196819,6.90100046961893e-06,BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_LPS_SRB_down|BSK_SAg_PBMCCytotoxicity_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down
Endrin,72-20-8,1.3691898153525e-06,4.14436465740039e-05,0.330373875983043,5.55589020859151e-06,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|AREA_UNDER_CROSS_CORRELATION
Imazalil,35554-44-0,2.73837963070501e-07,3.17388002593467e-06,0.86278611930159,1.1111780417183e-06,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_gOpiateK|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelective|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET|NVS_TR_rVMAT2|NVS_TR_hSERT|NVS_TR_rSERT|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Thiacloprid,111988-49-9,0,0,0.574328864227149,0,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth
Amoxapine,14028-44-5,0,0,1.34190478735089,0,TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Ticlatone,70-10-0,1.44125243721316e-08,4.50950343780098e-08,3.1960335701972,5.84830548272791e-08,TOX21_CASP3_CHO_viability
2-Chloro-N-phenylacetamide,587-65-5,4.32375731163948e-08,4.67208827297143e-08,9.25444267963197,1.75449164481837e-07,ACEA_ER_AUC_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_HSE_BLA_agonist_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_TR_LUC_GH3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
"1,2-Bis(chloromethyl)benzene",612-12-4,0,0,19.8652868718203,0,TOX21_RORg_LUC_CHO_Antagonist_viability
"2-Chloro-N,N-bis(2-chloroethyl)ethanamine",555-77-1,1.44125243721316e-08,1.76189836619164e-07,0.818011109419691,5.84830548272791e-08,TOX21_HRE_BLA_Agonist_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Tris(2-chloroethyl) phosphate,115-96-8,0.000117707086547199,0.000782679226688669,1.50389945885225,0.000477631108774388,IBI|NSDsd
Tetramethylthiuram monosulfide,97-74-5,4.61200779908212e-07,7.14417585191101e-06,0.645561908704759,1.87145775447293e-06,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ARE_BLA_agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_FXR_BLA_agonist_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_FLO_40hr_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
"N,N-Dimethyl-4-nitrosoaniline",138-89-6,1.44125243721316e-08,1.2099573219241e-08,11.9115973026325,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PPARg_BLA_antagonist_viability|TOX21_RAR_LUC_Agonist_viability|TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability
"N,N-Dimethyl-p-phenylenediamine",99-98-9,0,0,14.1021011256584,0,TOX21_AR_BLA_Antagonist_viability|TOX21_HDAC_Inhibition_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RXR_BLA_Agonist_viability
3-Dimethylaminophenol,99-07-0,2.93583121460321e-05,0.0163778216561423,0.0179256513854036,0.000119129982683167,TOX21_RT_HEPG2_FLO_24hr_viability
Acetamiprid,135410-20-7,2.24835380205253e-06,9.88698160588006e-05,0.22740548042644,9.12335655305553e-06,NVS_LGIC_hNNR_NBungSens|NVS_LGIC_rNNR_BungSens|SH-S5Y5 neurite outgrowth
Clothianidin,210880-92-5,2.88250487442632e-08,3.74374009279994e-07,0.769953256095431,1.16966109654558e-07,NVS_GPCR_rmAdra2B|NVS_LGIC_hNNR_NBungSens|SH-S5Y5 neurite outgrowth
Theophylline,58-55-9,1.87362816837711e-07,2.25355892873221e-06,0.831408553150709,7.60279712754628e-07,NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a
N-Methyl-2-pyrrolidone,872-50-4,0.00158105392362284,0.273810863204199,0.0577425564903078,0.00641559111455251,SH-S5Y5 neurite outgrowth
Olanzapine,132539-06-1,0,0,1.96448276637505,0,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PXR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
Thiamethoxam,153719-23-4,3.6031310930329e-07,0.000521315814159876,0.00691160903844729,1.46207637068198e-06,SH-S5Y5 neurite outgrowth
5-Chloro-2-methyl-3(2H)-isothiazolone,26172-55-4,2.15899615094532e-05,0.000412115344388076,0.52388152500147,8.76076161312641e-05,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
Aldoxycarb,1646-88-4,3.6031310930329e-07,1.83687658746678e-06,1.96155316999383,1.46207637068198e-06,ACEA_AR_antagonist_AUC_viability
Propoxur,114-26-1,0,0,1.58438348656833,0,NVS_ENZ_hAChE|NVS_ENZ_rAChE
Carbofuran,1563-66-2,6.19017921783053e-05,0.00725813989298381,0.0852860279506924,0.000251184720483164,NVS_ENZ_hAChE|NVS_ENZ_rAChE
3-Hydroxycarbofuran,16655-82-6,1.44125243721316e-08,0.00137738961046668,0.000104636511431565,5.84830548272791e-08,SH-S5Y5 neurite outgrowth
Oxamyl,23135-22-0,3.6031310930329e-07,1.33227633489142e-06,2.70449230288742,1.46207637068198e-06,APR_HepG2_MitoMass_72h_up|NVS_ENZ_hAChE|NVS_ENZ_rAChE
Aldicarb,116-06-3,3.74725633675422e-07,2.71341434884041e-06,1.38101146931563,1.52055942550926e-06,APR_HepG2_MitoMembPot_72h_dn|NVS_ENZ_rAChE|#SiNS|r|percent affected 4dpf|LD movement pattern (pearson) 5dpf|LD movement pattern (spearman) 4dpf|mean correlation|a L1 distmoved 4dpf|b D1 distmoved 4dpf|number network spikes|b D1 distmoved 5dpf|percent affected 4dpf|LD movement pattern (spearman) 5dpf
"1,1,3-Trimethyl-2-thiourea",2489-77-2,7.20626218606581e-08,1.85092685961621e-07,3.89332628062896,2.92415274136395e-07,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
N-Methyl-4-nitroaniline,100-15-2,0,0,13.1974008034216,0,TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
(N-6)-Methyladenine,443-72-1,4.33816983601162e-06,0.000103421337493861,0.419465648108556,1.7603399503011e-05,TOX21_MMP_ratio_down
Rifabutin,72559-06-9,4.45347003098867e-06,1.16115732251093e-05,3.83537178352225,1.80712639416292e-05,TOX21_MMP_ratio_up
Rifampicin,13292-46-1,4.75613304280343e-07,1.49638900394933e-06,3.17840683822914,1.92994080930021e-06,APR_HepG2_CellLoss_72h_dn|BSK_CASM3C_Proliferation_down|TOX21_AhR_LUC_Agonist_viability|TOX21_CASP3_CHO_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Dimethyl isophthalate,1459-93-4,0,0,2.87449139914105,0,TOX21_RT_HEK293_FLO_24hr_viability|TOX21_RT_HEPG2_FLO_00hr_ctrl_viability
Methylparaben,99-76-3,0,0,2.24165293422497,0,ACEA_AR_antagonist_AUC_viability
"Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate",1458-18-0,2.0912572863963e-05,0.000450975223315168,0.463718887042892,8.48589125543819e-05,TOX21_CASP3_CHO_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability
Thiophanate-methyl,23564-05-8,1.44125243721316e-08,3.1066588864225e-08,4.63923620167017,5.84830548272791e-08,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_CellLoss_24h_dn|APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_PBMCCytotoxicity_up
Cyclobendazole,31431-43-3,2.88250487442632e-08,1.34913040425365e-06,0.2136565053562,1.16966109654558e-07,TOX21_CASP3_CHO_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
2-Methoxy-4-vinylphenol,7786-61-0,2.88250487442632e-08,7.97837877939773e-08,3.61289549434493,1.16966109654558e-07,NVS_TR_hNET
Eugenol,97-53-0,4.32375731163948e-08,1.49448888662777e-05,0.0289313446913331,1.75449164481837e-07,BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE|SYNCHRONY_INDEX
2-Methoxy-4-nitroaniline,97-52-9,0,0,1.13581576672524,0,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|NCCT_HEK293T_CellTiterGLO|TOX21_CAR_Agonist_viabillity
"3,3'-Dimethoxybenzidine",119-90-4,5.19283253127902e-05,8.46612308941788e-05,6.13366056273117,0.000210714446542687,NVS_GPCR_r5HT1_NonSelective
Epirizole,18694-40-1,1.44125243721316e-08,2.15898876350199e-08,6.67559026511735,5.84830548272791e-08,TOX21_PR_BLA_Agonist_viability
"4'-Chloro-2',5'-dimethoxyacetoacetanilide",4433-79-8,1.44125243721316e-08,8.984239308297e-08,1.60420085413593,5.84830548272791e-08,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_p53_BLA_p4_viability
(E)-Anethole,4180-23-8,0,0,0.27520846407751,0,NUMBER_OF_SPIKES|NUMBER_OF_SPIKES_PER_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
Chlorotrianisene,569-57-3,6.25503557750512e-06,9.76506445890663e-06,6.40552410465653,2.53816457950391e-05,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability
4-Methoxyaniline,104-94-9,2.88250487442632e-08,3.8031877063855e-08,7.57918119472946,1.16966109654558e-07,TOX21_ERR_viability
6-Methoxy-2-benzothiazolamine,1747-60-0,4.32375731163948e-08,1.22267941257138e-06,0.353629681434344,1.75449164481837e-07,TOX21_RT_HEK293_GLO_32hr_viability
Brucine,357-57-3,5.76500974885265e-07,6.79074879410776e-07,8.48950524256598,2.33932219309116e-06,TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Prazosin,19216-56-9,0,0,5.83566250731559,0,TOX21_TR_LUC_GH3_Antagonist_viability
UK-333747,197077-55-7,0,0,2.09104935007564,0,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Fluvoxamine,54739-18-3,0,0,2.50730574266684,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
Ethylene glycol dimethyl ether,110-71-4,4.03550682419685e-07,1.07490243892743e-05,0.375430055607987,1.63752553516381e-06,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Dicrotophos,141-66-2,2.58560687236041e-05,8.66409949823296e-05,2.98427652277971,0.000104918600360139,NVS_ENZ_hES
Difenzoquat metilsulfate,43222-48-6,2.19070370456401e-06,1.94748363233214e-05,1.12488940507326,8.88942433374642e-06,NCCT_MITO_max_resp_rate_OCR_dn|NVS_ENZ_hES|NVS_GPCR_gOpiateK|NVS_GPCR_hAdra2A|NVS_GPCR_hAdra2C|NVS_GPCR_hM1|NVS_GPCR_hM2|NVS_GPCR_hM3|NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rAdra1B|NVS_GPCR_rAdra1_NonSelective|NVS_GPCR_rAdra2_NonSelective|NVS_GPCR_rmAdra2B|NVS_IC_rNaCh_site2|NVS_TR_hNET|NVS_GPCR_g5HT4|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Dimethyl sulfate,77-78-1,2.88250487442632e-06,4.30668934445464e-05,0.669308752937539,1.16966109654558e-05,NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NETWORK_BURST_PERCENTAGE
Piragliatin,625114-41-2,4.32375731163948e-08,9.95745411305958e-08,4.34223172162924,1.75449164481837e-07,APR_HepG2_MitoMass_72h_up
4-Chlorophenyl methyl sulfone,98-57-7,3.27164303247388e-06,0.0585920952000098,0.000558376180490868,1.32756534457924e-05,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
Saquinavir mesylate,149845-06-7,3.11310526438043e-06,4.02033829345732e-06,7.74339131969736,1.26323398426923e-05,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_TR_LUC_GH3_Antagonist_viability
3-Methyl-4-(methylthio)phenol,3120-74-9,1.72950292465579e-07,3.86167163656842e-07,4.47863797708257,7.01796657927349e-07,NVS_ENZ_rMAOAC|NVS_TR_gDAT
Aziprotryne,4658-28-0,1.44125243721316e-08,1.15829023189086e-09,124.4293008377,5.84830548272791e-08,TOX21_RT_HEK293_GLO_24hr_viability
Metribuzin,21087-64-9,2.88250487442632e-08,1.26741964926587e-07,2.27430975691119,1.16966109654558e-07,ACEA_AR_agonist_AUC_viability
1-Hexyl-3-methylimidazolium tetrafluoroborate,244193-50-8,1.01175921092364e-05,1.84812703071102e-05,5.4745111894954,4.10551044887499e-05,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability
1-Hexyl-3-methylimidazolium hexafluorophosphate,304680-35-1,0,0,1.22830978320416,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
1-Ethyl-3-methylimidazolium hexafluorophosphate,155371-19-0,8.64751462327897e-08,1.65112567585378e-05,0.0523734489127086,3.50898328963674e-07,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Tralopyril,122454-29-9,2.06099098521482e-06,7.40640795576951e-05,0.278271329033304,8.36307684030091e-06,ACEA_ER_AUC_viability|BSK_3C_Vis_down|BSK_CASM3C_Proliferation_down|BSK_SAg_Proliferation_down|TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability
Tetraconazole,112281-77-3,1.45566496158529e-06,8.1100976766808e-06,1.79487969148733,5.90678853755519e-06,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_IC_rCaBTZCHL|NVS_IC_rCaDHPRCh_L|NVS_TR_hDAT
Diflubenzuron,35367-38-5,2.73837963070501e-07,1.35951213005601e-06,2.01423699735007,1.1111780417183e-06,TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
5-Fluorouracil,51-21-8,3.93461915359193e-06,0.000136027422416789,0.289251908452418,1.59658739678472e-05,MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI|percent spikes in network spike|mean correlation|mutual information|number network spikes|number actively bursting electrodes|number active electrodes|mean firing rate
2-(Thiocyanomethylthio)benzothiazole,21564-17-0,4.29493226289522e-06,1.8361891199833e-05,2.33904678780271,1.74279503385292e-05,APR_HepG2_MitoMass_1h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_hAdra2A|NVS_GPCR_hDRD1|NVS_TR_hNET|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
"1,3-Diphenylguanidine",102-06-7,1.88804069274924e-06,3.74661362419179e-05,0.503932586098073,7.66128018237356e-06,NVS_GPCR_hM4|NVS_GPCR_rAdra1A|NVS_GPCR_rmAdra2B|NVS_GPCR_h5HT7|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|AREA_UNDER_CROSS_CORRELATION|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION
"1,3-Diiminobenz(f)isoindoline",65558-69-2,5.76500974885265e-08,4.77346910620037e-07,1.20771908659979,2.33932219309116e-07,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Indole,120-72-9,2.45012914326237e-07,2.19940967097495e-06,1.11399398465693,9.94211932063744e-07,TOX21_RT_HEPG2_FLO_32hr_ctrl_viability
Phenothiazine,92-84-2,9.36814084188555e-07,4.66401115569558e-06,2.00860172267071,3.80139856377314e-06,NVS_ENZ_rMAOAC|TOX21_MMP_rhodamine|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|NETWORK_BURST_PERCENTAGE|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
Guanabenz,5051-62-7,1.58537768093448e-07,1.34302995971146e-06,1.18044848476432,6.4331360310007e-07,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Phthalamide,88-96-0,4.2372821654067e-06,2.52666993202808e-06,16.7702243640726,1.71940181192201e-05,TOX21_RT_HEK293_GLO_32hr_viability
6-Aminonicotinamide,329-89-5,6.71623635741333e-06,9.63343921330059e-05,0.697179502429458,2.72531035495121e-05,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount_loss|CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount_loss|MFR|BR|ISI|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
2-Benzimidazolylurea,24370-25-0,4.28051973852309e-06,5.25728214864095e-12,8142077.25113183,1.73694672837019e-05,TOX21_RT_HEK293_FLO_08hr_viability|TOX21_RT_HEK293_FLO_16hr_viability
"2-Bromo-4,6-dinitroaniline",1817-73-8,3.12751778875256e-06,4.23316813304933e-06,7.38812560818292,1.26908228975196e-05,TOX21_SSH_3T3_GLI3_Antagonist_viability
"4-Nitro-1,2-phenylenediamine",99-56-9,1.44125243721316e-08,1.93466995392931e-08,7.44960366126523,5.84830548272791e-08,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CASP3_CHO_viability|TOX21_PXR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
"4-Chloro-1,2-diaminobenzene",95-83-0,0,0,3.88127934669865,0,TOX21_RT_HEPG2_FLO_40hr_ctrl_viability
2-Amino-5-nitrophenol,121-88-0,0,0,2.0208840650667,0,BSK_hDFCGF_Proliferation_down
2-Amino-4-nitrophenol,99-57-0,0,0,11.0818820742368,0,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide_viability|TOX21_CAR_Antagonist_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_08hr_viability
4-Amino-2-nitrophenol,119-34-6,0,0,2.04335888239906,0,TOX21_MMP_ratio_down
3-(Trifluoromethyl)aniline,98-16-8,5.26057139582804e-06,6.3302265800867e-06,8.3102418677658,2.13463150119569e-05,TOX21_RT_HEK293_FLO_24hr_viability
"3,4-Dichloroaniline",95-76-1,0,0,1.19508694416682,0,ACEA_AR_agonist_AUC_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
6-Amino-4-chloro-1-phenol-2-sulfonic acid,88-23-3,1.00887670604921e-07,6.91239643891451e-08,14.5951800502872,4.09381383790954e-07,TOX21_RT_HEK293_FLO_16hr_viability
2-Amino-4-chlorophenol,95-85-2,0,0,1.76704456198024,0,TOX21_MMP_ratio_down
"4-Chloro-1,3-diaminobenzene",5131-60-2,1.44125243721316e-08,8.00708284411681e-08,1.79997193144082,5.84830548272791e-08,TOX21_VDR_BLA_Agonist_viability
"1,3-Benzenediamine",108-45-2,2.37806652140172e-06,1.43722623029088e-05,1.65462226564041,9.64970404650105e-06,NCCT_MITO_inhib_resp_rate_OCR_up|NVS_ENZ_rMAOAC
"4-Nitro-1,3-benzenediamine",5131-58-8,0,0,7.35565281052755,0,TOX21_Aromatase_Inhibition_viability|TOX21_PXR_viability
4-Nitroaniline,100-01-6,1.44125243721316e-08,3.91023277338109e-08,3.6858481853676,5.84830548272791e-08,ACEA_AR_antagonist_AUC_viability|TOX21_ERR_viability
4-Aminobenzoic acid,150-13-0,4.14936576673669e-05,0.00125512378386182,0.33059414697487,0.000168372714847736,NVS_LGIC_rGABAR_NonSelective
C.I. Azoic Diazo Component 112,92-87-5,1.00887670604921e-07,3.358735204587e-07,3.00373993362561,4.09381383790954e-07,NVS_TR_gDAT|NVS_TR_hNET|NVS_TR_rNET
4-Biphenylamine,92-67-1,0,0,1.36230142978172,0,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Dapsone,80-08-0,1.62861525405087e-06,4.54332083818531e-05,0.3584636243082,6.60858519548254e-06,NVS_TR_gDAT|NVS_TR_hDAT|NVS_GPCR_h5HT6
"4,4'-Diaminobiphenyl methane",101-77-9,1.28271466911971e-06,1.26393505625832e-05,1.01485805205609,5.20499187962784e-06,NVS_TR_hDAT
4-Chloroaniline,106-47-8,4.79792936348261e-05,0.000520416147524793,0.921940909463045,0.000194690089520012,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|ACEA_ER_AUC_viability|BSK_hDFCGF_Proliferation_down
"1,4-Diaminoanthraquinone",128-95-0,2.63316820278845e-05,0.0713951526139347,0.00368816103948563,0.000106848541169439,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
"N-Phenyl-1,4-benzenediamine",101-54-2,0,0,3.98956481137279,0,TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_PGC_ERR_viability|TOX21_TR_LUC_GH3_Antagonist_viability
4-Aminophenol,123-30-8,1.44125243721316e-08,1.09543318518096e-08,13.1569177993733,5.84830548272791e-08,TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability
"4,4'-Oxydianiline",101-80-4,0.00012420713503903,0.00949281374027686,0.130843328898401,0.000504006966501491,NVS_TR_gDAT|NVS_TR_hDAT
2-Aminodiphenylamine,534-85-0,0,0,3.32236350949437,0,TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_RT_HEK293_GLO_08hr_viability|TOX21_TR_LUC_GH3_Antagonist_viability
"1,5-Naphthalenediamine",2243-62-1,4.35258236038375e-06,0.000130029224917767,0.334738776081792,1.76618825578383e-05,NVS_TR_hDAT
1-Naphthylamine,134-32-7,1.44125243721316e-08,7.71724134045815e-08,1.86757465994655,5.84830548272791e-08,BSK_3C_Proliferation_down
6-Amino-4-hydroxynaphthalene-2-sulfonic acid,90-51-7,2.88250487442632e-08,4.43228361766731e-08,6.50343056328009,1.16966109654558e-07,TOX21_SSH_3T3_GLI3_Antagonist_viability
2-Naphthylamine,91-59-8,1.44125243721316e-08,3.33661634841883e-07,0.431950301357286,5.84830548272791e-08,APR_HepG2_MitoMass_72h_up|APR_HepG2_MitoMembPot_24h_dn|NVS_TR_hNET|NUMBER_OF_SPIKES_PER_BURST_AVG|INTER_BURST_INTERVAL_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG
"6-Phenyl-1,3,5-triazine-2,4-diamine",91-76-9,2.88250487442632e-07,1.29392059673628e-05,0.222772933802662,1.16966109654558e-06,NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a
2-Amino-5-nitrothiazole,121-66-4,7.20626218606581e-08,7.33396654436318e-08,9.82587272859116,2.92415274136395e-07,TOX21_AhR_LUC_Agonist_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity
"4,4'-Diaminodicyclohexylmethane",1761-71-3,1.29712719349185e-07,2.52873929994397e-07,5.12954100693806,5.26347493445512e-07,TOX21_PR_BLA_Agonist_viability
Thiocarbazide,2231-57-4,1.35333603854316e-05,8.66313375235242e-06,15.6217839552075,5.49155884828151e-05,TOX21_PPARd_BLA_Agonist_viability
Thiosemicarbazide,79-19-6,4.13639449480177e-06,5.92868411661572e-06,6.97691834046129,1.67846367354291e-05,TOX21_CAR_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_FXR_BLA_antagonist_viability|TOX21_PPARd_BLA_antagonist_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability
6-Mercaptopurine monohydrate,6112-76-1,7.49451267350844e-07,1.05178019982625e-05,0.71255502573128,3.04111885101851e-06,TOX21_CAR_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PXR_viability|TOX21_RXR_BLA_Agonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability
Praziquantel,55268-74-1,0,0,15.1696390176844,0,TOX21_SSH_3T3_GLI3_Antagonist_viability
Thidiazuron,51707-55-2,1.54214010781808e-06,2.01533387812775e-05,0.765203286936622,6.25768686651886e-06,APR_HepG2_MitoMembPot_1h_dn|NVS_LGIC_bGABARa5|NVS_LGIC_rGABARa6|TOX21_MMP_ratio_down|NVS_GPCR_h5HT5A
"Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate",5493-45-8,0,0,5.19840223675956,0,TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Caprolactam,105-60-2,0.000558773569907543,0.00125990186311691,4.43505630291852,0.00226738803565361,TOX21_CAR_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability
"1,1'-Disulfanediyldiazepan-2-one",23847-08-7,5.76500974885265e-08,3.54920237616837e-08,16.2431136290301,2.33932219309116e-07,TOX21_CASP3_CHO_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
1-Phenyl-3-pyrazolidinone,92-43-3,1.44125243721316e-08,2.48944768660381e-08,5.78944657069443,5.84830548272791e-08,TOX21_ERb_BLA_Antagonist_viability
"Tris(2,3-epoxypropyl)isocyanurate",2451-62-9,8.64751462327897e-08,1.06641408299402e-06,0.810896513950805,3.50898328963674e-07,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability|APR_HepG2_MicrotubuleCSK_24h_up|BSK_SAg_Proliferation_down|STM_H9_Viability_norm|TOX21_CAR_Agonist_viabillity|TOX21_CAR_Antagonist_viability|TOX21_PXR_viability|TOX21_RT_HEK293_GLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
"cis-1,2,3,6-Tetrahydrophthalimide",1469-48-3,4.32375731163948e-08,9.98096290467608e-08,4.33200418930903,1.75449164481837e-07,TOX21_PR_BLA_Antagonist_viability
"5,5-Diphenylhydantoin",57-41-0,0,0,1.4249809968104,0,NVS_TR_hDAT|BD
"1H-Benzo[de]isoquinoline-1,3(2H)-dione",81-83-4,6.01002266317888e-06,5.61038507922798e-05,1.07123175652069,2.43874338629754e-05,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Thiouracil,141-90-2,3.45900584931159e-06,1.47546515950649e-05,2.34434939180031,1.4035933158547e-05,MFR|BR|%SiB|BD|IBI|#AE|#ABE|#NS|NSP|NSD|%SiNS|NS-ISI|NSDsd|#SiNS|r|MI
N-Nitrosomorpholine,59-89-2,5.29804395919558e-05,0.00127183485171078,0.416566974247405,0.000214983709545078,TOX21_RT_HEK293_GLO_08hr_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_24hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
Triphenylphosphine oxide,791-28-6,8.0710136483937e-07,4.58467227713757e-06,1.76043415112603,3.27505107032763e-06,NVS_GPCR_gOpiateK
Chlorpheniramine maleate,113-92-8,2.01775341209843e-07,1.3936156097314e-06,1.44785505989512,8.18762767581907e-07,NVS_ENZ_hES|NVS_GPCR_hDRD1|NVS_GPCR_hM2|NVS_IC_rNaCh_site2|NVS_TR_gDAT|NVS_TR_hDAT|NVS_TR_hNET
Perfluorodecanoic acid,335-76-2,1.14291318271004e-05,4.05745793218377e-05,2.81682078240281,4.63770624780323e-05,NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_D1
Perfluorooctanoic acid,335-67-1,6.58508238562693e-05,7.5282036309119e-05,8.74721608032443,0.000267209077505838,TOX21_ERb_BLA_Agonist_viability|TOX21_HRE_BLA_Agonist_viability
Perfluoroheptanoic acid,375-85-9,2.81044225256566e-06,7.46562727093319e-06,3.76450919738237,1.14041956913194e-05,APR_HepG2_MitoMass_72h_dn
Cyclanilide,113136-77-9,1.55655263219021e-06,3.58816718539783e-06,4.33801590551483,6.31616992134614e-06,TOX21_MMP_rhodamine
5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid,50594-66-6,4.71289546968704e-06,3.67311124933584e-05,1.28307996947798,1.91239589285203e-05,NCCT_MITO_basal_resp_rate_OCR_dn|NVS_GPCR_hAdoRA2a
Iodophthalein,386-17-4,0.000157528891387399,0.000794246413974293,1.98337554461401,0.00063921978926216,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
Gallic acid,149-91-7,7.04772441797236e-06,3.97226727389733e-06,17.742321782536,2.85982138105395e-05,TOX21_SSH_3T3_GLI3_Antagonist_viability
Rhein,478-43-3,3.53106847117225e-06,5.5187262751506e-05,0.639833957170831,1.43283484326834e-05,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
4-Nitrobenzoic acid,62-23-7,1.44125243721316e-08,5.02288100696289e-07,0.286937404094433,5.84830548272791e-08,NVS_LGIC_rGABAR_NonSelective
Terephthalic acid,100-21-0,2.45012914326237e-07,1.92693721840826e-07,12.7151477477107,9.94211932063744e-07,TOX21_RT_HEPG2_FLO_16hr_ctrl_viability|TOX21_RT_HEPG2_FLO_24hr_viability
Pyrazolone T,118-47-8,8.64751462327897e-08,3.51374066936927e-07,2.46105658811504,3.50898328963674e-07,ACEA_AR_agonist_AUC_viability
Endothal,145-73-3,2.16187865581974e-06,3.3403997079052e-06,6.47191607250942,8.77245822409186e-06,APR_HepG2_CellLoss_72h_dn|APR_HepG2_MicrotubuleCSK_24h_up|APR_HepG2_NuclearSize_72h_dn|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_SSH_3T3_GLI3_Agonist_viability|TOX21_SSH_3T3_GLI3_Antagonist_viability
Tamoxifen citrate,54965-24-1,9.51226608560686e-07,6.73347468452769e-06,1.41268312888505,3.85988161860042e-06,APR_HepG2_MitoMembPot_24h_dn|NVS_GPCR_hDRD1|NVS_GPCR_hM4|NVS_GPCR_hORL1|NVS_GPCR_hOpiate_mu|NVS_IC_rCaBTZCHL|NVS_TR_hDAT|NVS_GPCR_h5HT5A|NVS_GPCR_h5HT7|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NETWORK_BURST_PERCENTAGE
Tetrac,67-30-1,0.000200622339260072,0.00437401930159904,0.458668161767666,0.000814084123195725,NVS_GPCR_h5HT7
Tiratricol,51-24-1,8.44573928206912e-06,0.000303817108135845,0.277987613465559,3.42710701287855e-05,TOX21_RT_HEPG2_GLO_00hr_ctrl_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability
Hexanedioic acid,124-04-9,0.000299204005965452,0.00171608682119379,1.74352487455916,0.00121410821821431,ACEA_AR_agonist_AUC_viability|ACEA_AR_antagonist_AUC_viability
Decanedioic acid,111-20-6,7.97012597778878e-06,0.000809141625491464,0.0985010006492722,3.23411293194853e-05,ACEA_AR_antagonist_AUC_viability
Tridecanedioic acid,505-52-2,4.4678825553608e-07,2.76112712099409e-07,16.1813721700442,1.81297469964565e-06,TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEK293_GLO_40hr_viability
"2,4-Dichlorophenoxybutyric acid",94-82-6,1.23947709600332e-06,5.13293685806185e-06,2.41475227589559,5.029542715146e-06,NCCT_MITO_basal_resp_rate_OCR_dn|NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|INTER_BURST_INTERVAL_AVG_(SEC)|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG
Trimethylenediaminetetraacetic acid,1939-36-2,0.000883199493524225,0.00923644423773469,0.9562115796856,0.00358384159981566,TOX21_ERb_BLA_Agonist_viability|TOX21_PXR_viability
Pentetic acid,67-43-6,1.19623952288692e-06,2.04615258003023e-05,0.584628700010851,4.85409355066416e-06,TOX21_CAR_Agonist_viabillity|TOX21_RT_HEPG2_FLO_16hr_ctrl_viability
"2,4,5-Trichlorophenoxyacetic acid",93-76-5,1.45566496158529e-06,1.76070833007687e-06,8.26749630656739,5.90678853755519e-06,TOX21_MMP_fitc
4-Chlorophenoxyacetic acid,122-88-3,2.88250487442632e-07,3.23667611839259e-05,0.0890575630365463,1.16966109654558e-06,ACEA_AR_antagonist_AUC_viability
Malic acid,6915-15-7,0.00137106344352088,0.0181903242591838,0.753732272160387,0.00556349300571906,NVS_TR_gDAT
"2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)-2-propanol",120983-64-4,0,0,6.47364569062271,0,BSK_3C_Proliferation_down|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_16hr_ctrl_viability
Prothioconazole,178928-70-6,0,0,5.80184226015031,0,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_4H_SRB_down|BSK_CASM3C_SRB_down|BSK_SAg_Proliferation_down|BSK_hDFCGF_Proliferation_down
2-Hydroxy-3-phenoxypropyl prop-2-enoate,16969-10-1,0,0,0.141140534298161,0,TOX21_RT_HEPG2_GLO_08hr_ctrl_viability
D-Glucitol,50-70-4,0.00178138801239547,0.008204906415775,2.17112532687822,0.00722850557665169,BD|#SiNS
"2,4-Dinitrophenol",51-28-5,1.4124273884689e-06,4.53296555003998e-05,0.311590143996669,5.73133937307335e-06,TOX21_MMP_rhodamine
Dinex,131-89-5,1.54214010781808e-06,4.83243988081972e-06,3.19122461086157,6.25768686651886e-06,TOX21_AR_BLA_Antagonist_viability|TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_CASP3_HEPG2_viability|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_PXR_viability|TOX21_RORg_LUC_CHO_Antagonist_viability|TOX21_RT_HEK293_GLO_16hr_viability|TOX21_RT_HEK293_GLO_40hr_viability|TOX21_RT_HEPG2_GLO_08hr_ctrl_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability
Rafoxanide,22662-39-1,0.00011345539185742,0.000675506314105439,1.67956079000782,0.000460378607600341,TOX21_ERa_BLA_Antagonist_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p3_viability|TOX21_p53_BLA_p4_viability
2-Phenylphenol,90-43-7,0.000479216435373376,0.726454279401134,0.00659664963042722,0.00194456157300703,SH-S5Y5 viability
"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]",41481-66-7,8.25837646523141e-06,4.40750927737414e-05,1.8737059743982,3.35107904160309e-05,APR_HepG2_MitoMass_24h_dn|NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_hAdoRA1|NVS_GPCR_hAdoRA2a|NVS_GPCR_hOpiate_mu|NVS_GPCR_rOpiate_NonSelectiveNa|NVS_IC_rCaDHPRCh_L|NVS_TR_gDAT|NVS_TR_hNET|NVS_GPCR_g5HT4|NUMBER_OF_SPIKES_PER_BURST_AVG|BURST_PERCENTAGE_AVG_(SEC)|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ AVG|NUMBER_OF_SPIKES_PER_NETWORK_BURST_ STD|NUMBER_OF_ELECS_PARTICIPATING_IN_BURST_AVG|AREA_UNDER_CROSS_CORRELATION
"2,3,4,6-Tetrachlorophenol",58-90-2,3.04104264251977e-06,4.83511929851651e-06,6.28948833476107,1.23399245685559e-05,BSK_3C_Proliferation_down|BSK_3C_SRB_down|BSK_3C_Vis_down|BSK_4H_SRB_down|BSK_LPS_SRB_down|BSK_SAg_Proliferation_down|BSK_SAg_SRB_down|BSK_hDFCGF_Proliferation_down
"2,3,5,6-Tetrachlorophenol",935-95-5,3.31488060559027e-06,1.4385782181394e-05,2.30427554358331,1.34511026102742e-05,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
"((3,4-Dihydroxyphenyl)methylene)-Propanedinitrile",118409-57-7,0,0,6.21260984077033,0,TOX21_MMP_rhodamine
Quinalizarin,81-61-8,5.95237256569036e-06,8.56188725366432e-06,6.95217349789657,2.41535016436663e-05,BSK_3C_SRB_down
Clioquinol,130-26-7,3.08428021563617e-06,1.03392382054031e-05,2.98308265499133,1.25153737330377e-05,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PPARg_BLA_antagonist_viability
"4,6-Dichloro-1,3-benzenediol",137-19-9,0,0,2.70475854805243,0,TOX21_MMP_ratio_down|TOX21_MMP_rhodamine
4-Nitrophenol,100-02-7,0,0,16.7587531234721,0,TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_SSH_3T3_GLI3_Agonist_viability
Nitroxoline,4008-48-4,0,0,1.90648261990332,0,TOX21_AR_BLA_Antagonist_viability|TOX21_CASP3_CHO_viability|TOX21_ERR_viability|TOX21_PPARd_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_RT_HEPG2_GLO_24hr_ctrl_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability|TOX21_RT_HEPG2_GLO_40hr_viability|TOX21_RXR_BLA_Agonist_viability
Cloxyquin,130-16-5,2.98339254503124e-06,8.48691443511062e-06,3.51528528753496,1.21059923492468e-05,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881_viability|TOX21_ERb_BLA_Antagonist_viability|TOX21_PR_BLA_Antagonist_viability|TOX21_PXR_viability
Hydroquinone,123-31-9,8.979002683838e-06,0.00171798364392175,0.0522647739727084,3.64349431573949e-05,NUMBER_OF_SPIKES|MEAN_FIRING_RATE_HZ|NUMBER_OF_BURSTS|NUMBER_OF_SPIKES_PER_BURST_AVG|AREA_UNDER_CROSS_CORRELATION
C.I. Solvent Yellow 14,842-07-9,0.000282197227206337,0.000908995580544602,3.10449504096891,0.00114509821351812,ATG_FoxA2_CIS_up|BSK_SAg_Proliferation_down|NCCT_HEK293T_CellTiterGLO|TOX21_Aromatase_Inhibition_viability|TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PGC_ERR_viability|TOX21_PXR_viability
1-Naphthol,90-15-3,6.62976121118054e-07,1.53914343079649e-06,4.30743560250894,2.69022052205484e-06,NVS_ENZ_rMAOAC|TOX21_MMP_fitc
2-Naphthalenol,135-19-3,6.9972805826699e-05,0.000427206779165652,1.63791421951117,0.00028393523118644,NVS_ENZ_rMAOAC|NVS_ENZ_rMAOAP|NVS_ENZ_rMAOBC|NVS_TR_hNET|NVS_TR_rNET|NVS_GPCR_p5HT2C
"5-(5-Nitro-2-furyl)-1,3,4-oxadiazole-2-ol",2122-86-3,1.44125243721316e-08,1.961342211472e-08,7.3482966347392,5.84830548272791e-08,TOX21_SSH_3T3_GLI3_Antagonist_viability
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,77439-76-0,2.88250487442632e-08,9.66303406013533e-07,0.298302257498816,1.16966109654558e-07,TOX21_AR_BLA_Antagonist_viability|TOX21_RT_HEPG2_GLO_32hr_ctrl_viability
Bronopol,52-51-7,6.71623635741333e-06,3.45902671611609e-05,1.94165495343573,2.72531035495121e-05,APR_HepG2_MitoMembPot_24h_dn|NVS_GPCR_bAdoR_NonSelective|NVS_GPCR_rOpiate_NonSelective|NUMBER_OF_SPIKES|NUMBER_OF_BURSTS|BURST_DURATION_AVG_ (SEC)|BURST_PERCENTAGE_AVG_(SEC)|BURST_PERCENTAGE_STD_(SEC)|FULL_WIDTH_AT_HALF_HEIGHT_OF_CROSS_CORRELATION|SYNCHRONY_INDEX
C.I. Disperse Blue 27,15791-78-3,2.27573759835958e-05,3.70547277565983e-05,6.14155800390233,9.23447435722737e-05,BSK_3C_Proliferation_down|BSK_CASM3C_Proliferation_down|BSK_hDFCGF_Proliferation_down|BSK_hDFCGF_SRB_down|TOX21_ERa_LUC_VM7_Agonist_10nM_ICI182780_viability|TOX21_PXR_viability
Tris(2-hydroxyethyl) isocyanurate,839-90-7,1.61420272967874e-06,2.95751189000466e-06,5.45797545272489,6.55010214065526e-06,TOX21_RT_HEK293_FLO_16hr_viability|TOX21_RT_HEK293_FLO_32hr_viability|TOX21_RT_HEPG2_FLO_24hr_viability
1-Hydroxybenzotriazole,2592-95-2,1.03770175479348e-06,0.000575701798565578,0.0180249871961321,4.21077994756409e-06,TOX21_AR_BLA_Antagonist_viability|TOX21_ERb_BLA_Agonist_viability|TOX21_ERb_BLA_Antagonist_viability
CP-544439,230954-09-3,0,0,12.1460601966672,0,NCCT_MITO_basal_resp_rate_OCR_dn|NCCT_MITO_max_resp_rate_OCR_dn
Perfluorooctanesulfonic acid,1763-23-1,3.51089093705126e-05,0.00039790298393507,0.882348481614847,0.000142464721559252,APR_HepG2_MitoMass_72h_dn|NVS_GPCR_hAdoRA2a|NVS_GPCR_h5HT5A
Naphthalene-2-sulfonic acid,120-18-3,0,0,0.0135257564129854,0,SH-S5Y5 neurite outgrowth
Ensulizole,27503-81-7,2.68072953321648e-06,1.28630357134527e-05,2.08405666666451,1.08778481978739e-05,TOX21_AP1_BLA_Agonist_viability|TOX21_AR_BLA_Antagonist_viability|TOX21_GR_BLA_Antagonist_viability|TOX21_H2AX_HTRF_CHO_viability|TOX21_HDAC_Inhibition_viability|TOX21_HRE_BLA_Agonist_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_Agonist_viability|TOX21_p53_BLA_p5_viability
6-Mercaptopurine,50-44-2,1.72950292465579e-07,3.76066494480553e-06,0.459892851407752,7.01796657927349e-07,TOX21_CAR_Agonist_viabillity|TOX21_ERR_viability|TOX21_PGC_ERR_viability|TOX21_PR_BLA_Agonist_viability|TOX21_PXR_viability|TOX21_SBE_BLA_Agonist_viability|TOX21_SBE_BLA_Antagonist_viability|TOX21_VDR_BLA_antagonist_viability|TOX21_p53_BLA_p2_viability|TOX21_p53_BLA_p4_viability
2-Mercaptobenzimidazole,583-39-1,7.35038742978712e-07,5.74173232992375e-07,12.8016894683155,2.98263579619123e-06,TOX21_PR_BLA_Antagonist_viability
Benzothiazole,95-16-9,0,0,0.0134207699457019,0,SH-S5Y5 neurite outgrowth
2-Mercaptobenzothiazole,149-30-4,0,0,14.207620837123,0,APR_HepG2_MitoMembPot_24h_dn|APR_HepG2_MitoMembPot_72h_dn|NVS_TR_hNET
